0 Comentários
0 Compartilhamentos
465 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Transthyretin Amyloidosis ATTR Market – Earlier Diagnosis Expands Rare Disease Treatment AccessThe transthyretin amyloidosis, or ATTR, market is growing as awareness improves, diagnostic technologies advance, and new targeted therapies become available. The market was valued at USD 2.82 billion in 2024 and is projected to reach USD 5.8 billion by 2032, growing at a CAGR of 9.42%. 1177 ATTR amyloidosis is a rare, progressive condition caused by misfolded transthyretin protein that forms...0 Comentários 0 Compartilhamentos 357 Visualizações 0 Anterior
-
Tumor-Induced Osteomalacia Market: Emerging Trends in Rare Disease DiagnosisPolaris Market Research announces the release of its latest research report Tumor-induced Osteomalacia Market. The newly published report captures all the key forces influencing market transformation. As industries evolve amid technological shifts, economic disruptions, and regulatory changes, the study outlines how the market is responding and where it is headed. Designed to serve...0 Comentários 0 Compartilhamentos 179 Visualizações 0 Anterior
-
Aarskog-Scott Syndrome Treatment Market Size, Share & Forecast 2033According to the latest report published by Data Bridge Market Research, the Aarskog-Scott Syndrome Treatment Market CAGR ValueData Bridge Market Research analyses that the global aarskog-scott syndrome treatment market which was USD 3.01 billion in 2022, is expected to reach USD 4.88 million by 2030, and is expected to undergo a CAGR of 6.20% during the forecast period of 2023 to...0 Comentários 0 Compartilhamentos 14 Visualizações 0 Anterior
-
Acromesomelic Dysplasia Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Acromesomelic Dysplasia Market CAGR ValueData Bridge Market Research analyses that the acromesomelic dysplasia market is expected to reach USD 4.43 billion by 2030, which is USD 3 billion in 2022, and is expected to undergo a CAGR of 5% during the forecast period 2023 to 2030. In addition to the market...0 Comentários 0 Compartilhamentos 16 Visualizações 0 Anterior